![A novel MDMA analogue, UWA-101, that lacks psychoactivity and cytotoxicity, enhances L-DOPA benefit in parkinsonian primates]()
A novel MDMA analogue, UWA-101, that lacks psychoactivity and cytotoxicity, enhances L-DOPA benefit in parkinsonian primatesJohnston, T. H.; Millar, Z.; Huot, P.; Wagg, K.; Thiele, S.; Salomonczyk, D.; Yong-Kee, C. J.; Gandy, M. N.; McIldowie, M.; Lewis, K. D.; Gomez-Ramirez, J.; Lee, J.; Fox, S. H.; Martin-Iverson, M.; Nash, J. E.; Piggott, M. J.; Brotchie, J. M. · The FASEB Journal · 2012